Duality Advisers, LP Deciphera Pharmaceuticals, Inc. Transaction History

Duality Advisers, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$6.87 - $11.11 $1.17 Million - $1.9 Million	-170,737 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$7.7 - $37.13 $1.12 Million - $5.4 Million	145,306 Added 571.37%	170,737 $1.67 Million
Q3 2021 Nov 08, 2021	BUY	$26.46 - $37.15 $519,171 - $728,920	19,621 Added 337.71%	25,431 $864,000
Q2 2021 Aug 09, 2021	SELL	$32.73 - $47.95 $333,649 - $488,802	-10,194 Reduced 63.7%	5,810 $213,000
Q1 2021 May 13, 2021	SELL	$40.39 - $56.73 $631,578 - $887,087	-15,637 Reduced 49.42%	16,004 $718,000
Q4 2020 Feb 09, 2021	BUY	$51.77 - $66.18 $1.64 Million - $2.09 Million	31,641 New	31,641 $1.81 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.